This is the home for the sole proprietorship of Professor Mattias Collin called GlycImmun. It is mainly handling intellectual property (patents, licenses) related to Mattias’ research group Infection and Immunomodulation at Lund University.
In addition, GlycImmun can provide consulting in the biotechnological and biopharmaceutical realm, especially concerning autoimmune diseases, antibody glycosylation, antibody characterization, and antibody modifying enzymes.
One of GlycImmun’s main collaborators is Genovis AB with their innovative portfolio of enzyme tools for research as well as the biopharmaceutical and biotechnology industries.
